Novo Nordisk, the Danish drug maker, is now the largest European company by market cap at over $500 billion. This is larger than the GDP of Denmark, the country where the company is based. There is also no reason to think sales of drugs such as Ozemoic and will not continue to grow rapidly.

Ozempic maker now worth more than $500 billion